Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT00080860
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically or cytologically confirmed carcinoma of the breast
* Stage II, III, or IV infiltrating disease
* Unilateral or bilateral AND unifocal or multifocal disease
* Received at least 1 course of prior preoperative therapy (chemotherapy, hormonal therapy, and/or biologic therapy) AND had any of the following responses:
* Clinical complete response, partial response, no change, or disease progression
* Hormone receptor status:
* Not specified
PATIENT CHARACTERISTICS:
Age
* Over 18
Sex
* Female
Menopausal status
* Not specified
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Hemoglobin \> 7.0 g/dL
* Platelet count \> 50,000/mm\^3
* WBC \> 2,000/mm\^3
Hepatic
* PT and PTT \< 1.5 times normal
Renal
* Not specified
Other
* Not pregnant or nursing
* Negative pregnancy test
PRIOR CONCURRENT THERAPY:
Biologic therapy
* See Disease Characteristics
Chemotherapy
* See Disease Characteristics
Endocrine therapy
* See Disease Characteristics
Radiotherapy
* No prior definitive breast radiotherapy to the target breast
Surgery
* No prior axillary surgery on the side of the sentinel lymph node
Other
* More than 3 days since prior radionuclide scan (e.g., bone scan, positron-emission tomography scan, or MUGA scan)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00080860
Study Brief:
Protocol Section:
NCT00080860